Covered recipient · General Payments record
MICHELLE MERSMANN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,047.33
- Reported across 137 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $654.15 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $195.64 | 14 |
| Novo Nordisk AS | $176.39 | 5 |
| Lilly USA, LLC | $70.89 | 4 |
| ABBVIE INC. | $61.93 | 4 |
| Acerta Pharma LLC | $48.33 | 3 |
| Exact Sciences Corporation | $45.25 | 2 |
| Axsome Therapeutics, Inc. | $42.34 | 2 |
| GlaxoSmithKline, LLC. | $13.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.15 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107653174 | CMS |
| ABBVIE INC. | $15.71 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107653176 | CMS |
| ABBVIE INC. | $14.36 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107653178 | CMS |
| ABBVIE INC. | $15.71 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107653180 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.27 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105597133 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.51 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105630143 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.55 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105497615 | CMS |
| Axsome Therapeutics, Inc. | $20.91 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148394395 | CMS |
| Axsome Therapeutics, Inc. | $21.43 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148394397 | CMS |
| Exact Sciences Corporation | $23.33 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114786744 | CMS |
| Exact Sciences Corporation | $21.92 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114786750 | CMS |
| GlaxoSmithKline, LLC. | $13.38 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115978619 | CMS |
| Lilly USA, LLC | $17.80 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135836348 | CMS |
| Lilly USA, LLC | $17.49 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135826013 | CMS |
| Lilly USA, LLC | $15.50 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135758754 | CMS |
| Lilly USA, LLC | $20.10 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135834484 | CMS |
| Novo Nordisk Inc | $13.92 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100644063 | CMS |
| Novo Nordisk Inc | $15.51 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100638308 | CMS |
| Novo Nordisk Inc | $13.62 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100276046 | CMS |
| Novo Nordisk Inc | $20.48 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100280600 | CMS |
| Novo Nordisk Inc | $112.86 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100271862 | CMS |
| PFIZER INC. | $7.84 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131810994 | CMS |
| PFIZER INC. | $13.34 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130974566 | CMS |
| PFIZER INC. | $19.15 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131170240 | CMS |
| PFIZER INC. | $15.15 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131291298 | CMS |
| PFIZER INC. | $0.98 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131713460 | CMS |
| PFIZER INC. | $12.51 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131716082 | CMS |
| PFIZER INC. | $15.55 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131652852 | CMS |
| PFIZER INC. | $14.30 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131465512 | CMS |
| PFIZER INC. | $15.03 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131762746 | CMS |
| PFIZER INC. | $17.93 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131743274 | CMS |
| PFIZER INC. | $16.66 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131981787 | CMS |
| PFIZER INC. | $14.51 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131944024 | CMS |
| PFIZER INC. | $18.22 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131111522 | CMS |
| PFIZER INC. | $14.47 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131100427 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.